blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2791141

EP2791141 - Tofacitinib mono-tartrate salt [Right-click to bookmark this link]
Former [2014/43]TOFACITINIB SALTS
[2016/32]
StatusNo opposition filed within time limit
Status updated on  15.12.2017
Database last updated on 23.04.2024
FormerThe patent has been granted
Status updated on  06.01.2017
FormerGrant of patent is intended
Status updated on  28.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL, IS		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
[2014/43]
Inventor(s)01 / COUTABLE, ludovic
Neunkirchenweg 103
89077 Ulm / DE
02 / ALBRECHT, Wolfgang
Alfred-Mendler-Weg 25/1.
89075 Ulm / DE
03 / GUSERLE, Richard
Sternenweg 6
89359 Kötz / DE
 [2014/43]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2017/06]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2014/43]Nachshen, Neil Jacob
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date12805898.913.12.2012
[2017/06]
WO2012US69355
Priority number, dateUS201161576199P15.12.2011         Original published format: US 201161576199 P
[2014/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013090490
Date:20.06.2013
Language:EN
[2013/25]
Type: A1 Application with search report 
No.:EP2791141
Date:22.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2013 takes the place of the publication of the European patent application.
[2014/43]
Type: B1 Patent specification 
No.:EP2791141
Date:08.02.2017
Language:EN
[2017/06]
Search report(s)International search report - published on:EP20.06.2013
ClassificationIPC:C07D487/04, A61K31/519, A61P35/00
[2014/43]
CPC:
C07D487/04 (EP); A61P35/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Mono-Tartratsalz von Tofacitinib[2016/32]
English:Tofacitinib mono-tartrate salt[2016/32]
French:Sel de mono-tartrate de Tofacitinib[2016/32]
Former [2014/43]SALZE VON TOFACITINIB
Former [2014/43]TOFACITINIB SALTS
Former [2014/43]SELS DE TOFACITINIB
Entry into regional phase15.07.2014National basic fee paid 
15.07.2014Designation fee(s) paid 
15.07.2014Examination fee paid 
Examination procedure15.07.2014Examination requested  [2014/43]
02.03.2015Amendment by applicant (claims and/or description)
04.09.2015Despatch of a communication from the examining division (Time limit: M04)
11.01.2016Reply to a communication from the examining division
25.07.2016Communication of intention to grant the patent
28.11.2016Fee for grant paid
28.11.2016Fee for publishing/printing paid
28.11.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16202511.8  / EP3170826
EP16202520.9  / EP3170827
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.09.2015
Opposition(s)09.11.2017No opposition filed within time limit [2018/03]
Fees paidRenewal fee
22.12.2014Renewal fee patent year 03
22.12.2015Renewal fee patent year 04
23.12.2016Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.12.2012
AL08.02.2017
AT08.02.2017
CY08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
MK08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
TR08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
IS08.06.2017
PT08.06.2017
[2020/33]
Former [2020/15]HU13.12.2012
AT08.02.2017
CY08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
MK08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
TR08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2019/51]HU13.12.2012
AT08.02.2017
CY08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
MK08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2019/47]HU13.12.2012
AT08.02.2017
CY08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2019/31]HU13.12.2012
AT08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2019/30]AT08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
MC08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2018/14]AT08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SI08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2017/51]AT08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SK08.02.2017
SM08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2017/50]AT08.02.2017
CZ08.02.2017
DK08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
PL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SK08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2017/49]AT08.02.2017
CZ08.02.2017
EE08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
IT08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
RO08.02.2017
RS08.02.2017
SE08.02.2017
SK08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2017/48]AT08.02.2017
CZ08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
RS08.02.2017
SE08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Former [2017/41]AT08.02.2017
ES08.02.2017
FI08.02.2017
HR08.02.2017
LT08.02.2017
LV08.02.2017
NL08.02.2017
RS08.02.2017
SE08.02.2017
BG08.05.2017
NO08.05.2017
GR09.05.2017
PT08.06.2017
Cited inInternational search[AD]WO03048162  (PFIZER PROD INC [US], et al) [AD] 1,2,11-18 * the whole document *;
 [A]WO2007012953  (PFIZER PROD INC [US], et al) [A] 1,2,11-18 * Formula Ia; page 12, line 26 - line 32; examples 11-13 *;
 [IDP]WO2012135338  (RATIOPHARM GMBH [DE], et al) [IDP] 1,2,11-18 * page 7, line 3 - line 9; example -; claims 1-2 *
by applicantWO03048126
 WO0142246
 WO02096909
 WO03048162
 WO2012135338
    - "Mild and Efficient DBU-Catalyzed Amidation of Cyanoacetates", ORG. LETT, (2009), vol. 11, no. 9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.